Cargando…
Elevation in fibroblast growth factor 23 and its value for identifying subclinical atherosclerosis in first-degree relatives of patients with diabetes
Accumulating evidence supported an association between diabetes and fibroblast growth factor 23 (FGF23). The goal of the present study was to explore alteration in serum FGF23 levels and to assess its value for identifying subclinical atherosclerosis in normoglycemic individuals with a first-degree...
Autores principales: | Hu, Xiang, Ma, Xiaojing, Luo, Yuqi, Xu, Yiting, Xiong, Qin, Pan, Xiaoping, Bao, Yuqian, Jia, Weiping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5048154/ https://www.ncbi.nlm.nih.gov/pubmed/27698482 http://dx.doi.org/10.1038/srep34696 |
Ejemplares similares
-
Elevated serum fibroblast growth factor 23 levels as an indicator of lower extremity atherosclerotic disease in Chinese patients with type 2 diabetes mellitus
por: He, Xingxing, et al.
Publicado: (2017) -
Association of androgen with gender difference in serum adipocyte fatty acid binding protein levels
por: Hu, Xiang, et al.
Publicado: (2016) -
Contribution of serum adipocyte fatty acid‐binding protein levels to the presence of microalbuminuria in a Chinese hyperglycemic population
por: Hu, Xiang, et al.
Publicado: (2017) -
Glycemic variability is associated with subclinical atherosclerosis in Chinese type 2 diabetic patients
por: Mo, Yifei, et al.
Publicado: (2013) -
Relationship between serum osteocalcin level and carotid intima-media thickness in a metabolically healthy Chinese population
por: Luo, Yuqi, et al.
Publicado: (2015)